Dilated cardiomyopathy due to chemicals (Q98617): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 15:11, 16 August 2026
Dilated cardiomyopathy due to chemical exposure is the presence of dilated cardiomyopathy in association with exposure to chemicals that are known to be associated with cardiomyopathy including lead, cobalt, and arsenic.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_126460337 |
||
| English | Dilated cardiomyopathy due to chemicals |
Dilated cardiomyopathy due to chemical exposure is the presence of dilated cardiomyopathy in association with exposure to chemicals that are known to be associated with cardiomyopathy including lead, cobalt, and arsenic. |
Statements
CID11:ID_126460337
0 references
dki-india-ID_126460337
0 references
Concluído
0 references
15 August 2026
0 references
